Literature DB >> 308031

Group-specific component, alpha1-antitrypsin and esterase D in Canadian Eskimos.

D W Cox, N E Simpson, R Jantti.   

Abstract

Three genetic markers - group-specific component (Gc), alpha1-antitrypsin, and esterase D - were examined in a population of Eskimos from Igloolik in the eastern Canadian Arctic. Gc and esterase D were found to be polymorphic. In addition to the common Gc types, an anodal variant called Gc Igloolik was found, probably identical to previously reported Gc Eskimo. Gene frequencies were Gc1: 0.6524, Gc2: 0.3373, GcIgl: 0.0104, for 338 Eskimos. Genetic types of alpha1-antitrypsin (Pi types) were mostly M, with two MS sibs who were half Caucasian, in 170 Eskimos. Frequencies of the esterase D allele in 336 Eskimos were EsD1: 0.7083, EsD2: 0.2917. The frequencies of Gc2 and EsD2 are both higher than are found in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308031     DOI: 10.1159/000152976

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  5 in total

1.  [Population genetic examination of esterase D in the Lübeck area (author's transl)].

Authors:  J Weissmann; T Tsuji; O Pribilla
Journal:  Z Rechtsmed       Date:  1979-07-17

Review 2.  Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations.

Authors:  M I Kamboh; R E Ferrell
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

3.  Gc X and Gc Y revealed by immunofixation electrophoresis.

Authors:  K Hjalmarsson
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

4.  Group-specific component. Report on the First International Workshop, Collège de France--July 27-28, 1978--Paris.

Authors:  J Constans; H Cleve
Journal:  Hum Genet       Date:  1979-04-27       Impact factor: 4.132

5.  Five new Gc variants detected by isoelectric focusing in agarose gel.

Authors:  M Thymann; K Hjalmarsson; M Svensson
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.